These medicines are licensed for different indications some specifically for type 2 diabetes (e.g., Ozempic, Trulicity), while others are licensed for weight management (e.g., Wegovy, Saxenda) in line with NICE guidance
With an average weight reduction of 12.4% achieved in trials, it provides an attractive non-injection alternative
While mechanisms remain speculative, one possible explanation is that such hair loss is down to rapid weight loss and its associated metabolic changes and nutritional deficiencies rather than the medications themselves
"3 ways the GLP-1 market has changed shape this year." August 2025
Buccal/sublingual compositions
I dont do any gym workouts, can I use L-Carnitine